Skip to content

The randomized control trial on Chinese herbs xianglian solution and ointment in treating tinea pedis

The randomized control trial on Chinese herbs xianglian solution and ointment in treating tinea pedis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10000834
Enrollment
Unknown
Registered
2010-03-28
Start date
2010-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinea pedis

Interventions

Group A:Patients of Test group dunk feet in Chinese herb XiangLian lotion about 20 minutes once a day, then apply XiangLian cream twice every day.
Group B:Patients in the control group use Terbinafine cream twice a day.

Sponsors

Guangdong provincail hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Male and female aged 18 to 65 years old; 2. Able and willing to provide signed informed consent; 3. Patients with interdigital, or parts of palmoplantar blisters, dipping, or chapped, keratosis, squamous skin rash; 4. Dander microscopic fungi and / or culture-positive

Exclusion criteria

Exclusion criteria: 1. Patients in past 3 months had received systemic antifungal agents or local antifungal treatment in the past two weeks. 2. Received long-term corticosteroids or immunosuppressant. 3. Women who are lactating and pregnant. 4. Patients received radiation therapy, anti-virus, anti-bacterial, or anti-worm treatment within the past two weeks. 5. Patients with onychomycosis or other bacterial infection erysipelas. 6. Patients with cardiovascular, liver, kidney, brain and hematopoietic diseases; suffering from mental illness, cancer, and autoimmune diseases.

Design outcomes

Primary

MeasureTime frame
Cure and not cure rate;

Secondary

MeasureTime frame
Recurrence (including relapse or reinfection) rate;The quality of life;Clinical evaluation of clinical symptoms;Parameters of mycology;

Countries

China

Contacts

Public ContactRuiqiang Fan
fanrq54@126.com+86 136 0901 5438

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026